en

PRODUCT DETAIL

Bortezomib Hospira 1 mg prášok na injekčný roztok

Code 9884C
MA number EU/1/16/1114/004
Product Form: plv ino 1x1 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX32 Bortezomib
Shelf life: 36
Container: glass vial
Route of admin.: Subcutaneous and intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.10.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 12.05.2021
eu-flag.png sk-flag.png